THE USE OF MEDOSATIN AS HYPOLIPEDEMIC THERAPY IN PATIENT AFTER RECONSTRUCTIVE OPERATIONS ON CORONARY ARTERIES
https://doi.org/10.51523/2708-6011.2007-4-3-3
Abstract
This time some operative methods of treatment of ischemic heart disease such as surgical and endovascular myocardial revascularization are used. But myocardial revascularization doesn’t solve the problem of coronary atherosclerosis because one of fundamental factors of progression of atherosclerosis - dyslipidemia is remained. The results of use of medostatin for correction of lipid disturbances in patients after reconstructive operations on coronary arteries are represented in given article. Medostatin demonstrated good hypolipidemic effects and safety during treatment in given group of patients.
References
1. Острая эндотелиальная дисфункция при проведении коронарной ангиопластики и стентирования / М. Г. Гомельяненко [и др.]; Российский Национальный конгресс кардиологов «От исследований к стандартам лечения». - М., 2003. - С. 238.
2. Влияние лечения симвастатином на предупреждение рестеноза после ангиопластики коронарных артерий: данные 6-месячного наблюдения / И. Е. Чернышова [и др.] // Кардиология. - 2004. - № 6. - С. 13-18.
3. Еarly changes in plasma antioxidant and lipid peroxidation level following coronary aftery bypass surgery: acomplex response / L. Hadjinikolaou [et al.] // Eur. J. Cardiothorac Surg. - 2003. - Vol. 23. -P. 969-975.
4. Estination of the LDL cholesterol in plasma without use of the preperative ultrasentrifuge / W. Friedwald [et al.] // Clin Chem. - 1972. - Vol. 18. - P. 499-502.
5. Оценка липидных показателей и индексов при ишемической болезни сердца / А. М. Климов [и др.]. - Кардиология. - 1983. - № 10. - С. 82-83.
6. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholestelemic humans / O. Tamai [et al.]. - Circulation. - 1997. - Vol. 95. - P. 76-82.
7. Beneficial effects of cholesterol lowering therapy on the coronary endothelium in patients with coronary artery disease / C. B. Treasure [et al.] // NEngl. J med. - 1995. - Vol. 332. - P. 481-787.
8. Влияние терапии розувастатином на липидный спектр, факторы воспаления и функцию эндотелия у больных ишемической болезнью сердца / И. В. Сергиенко [и др.] // Кардиология. - 2006. - № 5. - С. 4-8.
Review
For citations:
Siluyanov V.V. THE USE OF MEDOSATIN AS HYPOLIPEDEMIC THERAPY IN PATIENT AFTER RECONSTRUCTIVE OPERATIONS ON CORONARY ARTERIES. Health and Ecology Issues. 2007;(3):17-21. (In Russ.) https://doi.org/10.51523/2708-6011.2007-4-3-3
Views: 231
Email this article 